Key Developments For Sun Healthcare Group, Inc.
Sun Healthcare Group, Inc. (SUNH.O) (Nasdaq)
Sun Healthcare Group Reaffirms FY 2009 Guidance-Conference Call
Sun Healthcare Group reaffirmed fiscal 2009 guidance issued in September 2009. According to Reuters Estimates, analysts are expecting the Company to report earnings per share (EPS) of $1.08 and net profit of $48 million on revenue of $1.881 billion for fiscal 2009.
Sun Healthcare Group Announces Acquisition Of Allegiance Hospice Group, Inc.
Sun Healthcare Group announced that its subsidiary, SolAmor Hospice Corporation, has completed the acquisition of Allegiance Hospice Group, Inc. Allegiance is a privately held, Medicare certified hospice company headquartered in Lowell, Mass. that provides services to approximately 300 hospice patients in Maine, Massachusetts and New Hampshire.
Sun Healthcare Group Lowers FY 2009 Guidance
Sun Healthcare Group lowered its fiscal 2009 guidance and expects revenue of $1.876-$1.890 billion compared to previous guidance of $1.919-$1.933 billion, EBITDAR of $248.0-$251.0 million compared to previous guidance of $260.0-$264.0 million, EBITDA of $174.5-$177.5 million compared to previous guidance of $185.0-$189.0 million, income from continuing operations of $46.9-$48.2 million compared to previous guidance of $51.3-$52.8 million and diluted earnings per share (EPS) of $1.07-$1.10 compared to previous guidance of $1.15-$1.19. According to Reuters Estimates, analysts were expecting the Company to report revenues of $1.879 billion and EBITDA of $182.4 million and EPS of $1.09 for fiscal 2009. The revised guidance reflects the estimated impact of changes in the Medicare and Medicaid reimbursement environments.
Sun Healthcare Group Issues FY 2009 Guidance Above Analysts' Estimates; Reaffirms FY 2008 Guidance
Sun Healthcare Group announced that for fiscal 2009, it expects revenue of $1.919.0-$1.933.0 billion, EBITDAR of $260.0-$264.0 million, EBITDA of $185.0-$189.0 million, Income from continuing operations of $51.3-$52.8 million and diluted earnings per share (EPS) of $1.15-$1.19. The Company also reaffirmed fiscal 2008 guidance that was announced on October 1, 2008. According to Reuters Estimates, analysts were expecting the Company to report revenues of $1.893 billion and EBITDA of $177 million, EBIT of $134 million and EPS of $1.11 for fiscal 2009; revenues of $1.829 billion and EPS of $0.92 for fiscal 2008.
Sun Healthcare Group Reaffirms FY 2008 Guidance
Sun Healthcare Group reaffirmed its recent upwardly revised fiscal 2008 guidance. Earlier Sun Healthcare Group revised fiscal 2008 guidance and expects revenue to be in the range of $1.818-$1.823 billion, EBITDA in the range of $162.0-$164.0 million, income from continuing operations in the range of $40.2-$41.4 million and diluted earnings per share (EPS) in the range of $0.91-$0.94. According to Reuters Estimates, analysts were expecting the Company to report revenues of $1.823 billion, EBITDA of $163.2 million, net income of $40.6 million and EPS of $0.92 for the same period.
